Archives of Suicide Research

, Volume 4, Issue 2, pp 143–155 | Cite as

Psychopharmacological therapy and suicide of inpatients with depressive psychoses

  • Martin Krupinski
  • Alfred Fischer
  • Renate Grohmann
  • Rolf R. Engel
  • Matthias Hollweg
  • Hans-Jürgen Möller
Article
  • 11 Downloads

Abstract

Data on the psychopharmacological treatment of 3792 inpatients with mono- or bipolar depression during a twelve-year period were routinely documented in a systematic way by means of an electronic data processing system. Thirty-three of these patients committed suicide while in hospital; the remaining patients were used as controls (n = 3759). To identify possible differences in the pharmacological treatment of suicides and controls the data were classified according to the following drugs and drug groups: antidepressants, neuroleptics, tranquilizers, hypnotics, lithium, biperiden, beta-adrenergic blocking drugs, placebos and others. A comparison was made of how frequently the drugs were prescribed and of the mean number of prescriptions of neuroleptics, tranquilizers and antidepressants; the latter were in addition differentiated in sedating and non-sedating drugs. Moreover the mean daily dose of frequently used substances was compared. Whereas no significant difference for the groups was found with respect to the percentage of patients undergoing neuroleptic treatment, the mean number of prescriptions of neuroleptics was significantly higher at 1.3 per patient for the suicides than for the controls at 0.8 per patient. Furthermore a tendency towards a lower frequency of the prescription of lithium together with a lower mean dosage emerged for the suicides. No other hints of differences in the psychopharmacological treatment of suicides were found.

affective psychoses depression psychopharmacology major affective disorder suicide suicidal behavior 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahrens, B., Grof, P., Moller, H. J., Muller-Oerlinghausen, B. & Wolf, T. (1995). Extended survival of patients on long-term lithium treatment. Canadian Journal of Psychiatry, 40(5), 241-6.Google Scholar
  2. Cohen, S., Leonard, C. V., Farberow, N. L. & Shneidman, E. S. (1964). Tranquilizers and suicide in the schizophrenic patient. Archives of General Psychiatry, 11 312-321.Google Scholar
  3. Coppen, A. (1994). Depression as a lethal disease: Prevention strategies. Journal of Clinical Psychiatry, 55(4,suppl), 37-45.Google Scholar
  4. Finzen, A. (1988). Der Patientensuizid:Untersuchungen, Analysen, Berichte zur Selbsttötung psychisch Kranker während der Behandlung. Bonn: PsychiatrieVerlag.Google Scholar
  5. Galdi, J. & Hirsch, S. R. (1983). The causality of depression in schizophrenia. British Journal of Psychiatry, 142 621-625.Google Scholar
  6. Glen, A., Dodd, M., Hulme, N. & Kreitman, N. (1979). Mortality on lithium. Neuropsychobiology, 5 167-169.Google Scholar
  7. Goldney, R. D., Positano, S., Spence, N. & Rosenman, S. (1985). Suicide in association with psychiatric hospitalisation. Australian and New Zealand Journal of Psychiatry, 19 177-183.Google Scholar
  8. Grohmann, R., Rüther, E. & Schmidt, L. G. (Eds.). (1994). Unerwünschte Wirkungen von Psychopharmaka. Ergebnissse der AM ÜPStudie. Berlin Heidelberg: Springer.Google Scholar
  9. Guy, W. & Ban, T. A. (Eds.). (1982). The AMDP-System. Manual for the assessment and documentation of psychopathology. Berlin Heidelberg, New York: Springer.Google Scholar
  10. Guze, S. & Robins, E. (1970). Suicide and primary affective disorder. British Journal of Psychiatry, 117 437-438.Google Scholar
  11. Helmchen, H. (1985). The AMDP. In P. Pichot (Ed.), Psychiatry. The state of the art. Vol. 1. Clinical Psychopathology, nomenclature and classification(pp. 141-146). New York: Plenum Press.Google Scholar
  12. Hessö, R. (1977). Suicide in Norwegian, Finnish, and Swedish psychiatric hospitals. Archiv für Psychiatrie und Nervenkrankheiten, 224(2), 119-27.Google Scholar
  13. Hussar, A. E. (1962). Effect of tranquilizers on medical morbidity and mortality in a mental hospital. Journal of the American Medical Association, 179 682-686.Google Scholar
  14. Kapur, S., Mieczkowski, T. & Mann, J. J. (1992). Antidepressant medications and the relative risk of suicide attempt and suicide. Journal of the American Medical Association, 268(24), 3441-5.Google Scholar
  15. Lepkifker, E., Horesh, N. & Floru, S. (1985). Long-term lithium prophylaxis in recurrent unipolar depression. Acta psychiatrica Belgica, 85 434-443.Google Scholar
  16. Litovitz, T., Bailey, K., Schmitz, B., Holm, K. & Klien-Schwarz, W. (1991). 1990 annual Report of the American Association of Poison Control Centers National Data Collection System. American Journal of Emergency Medicine, 9 461-509.Google Scholar
  17. Menninger, K. (1938). Man against Himself. London: Harrap.Google Scholar
  18. Modestin, J. (1985). Antidepressive therapy in depressed clinical suicides. Acta psychiatrica Scandinavica, 71 111-116.Google Scholar
  19. Modestin, J. & Schwarzenbach, J. (1992). Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta psychiatrica Scandinavica, 85 173-175.Google Scholar
  20. Möller, H.J. (1992). Antidepressants - Do they decrease or increase suicidality. Pharmacopsychiatry, 25 249-253.Google Scholar
  21. Möller, H.J. (1995). Suizidalität unter Antidepressivabehandlung. In M. Wolfersdorf & W. P. Kaschka (Eds.), Suizidalität - Die biologische Dimension. Berlin Heidelberg: Springer.Google Scholar
  22. Möller, H.J.& Zerssen, D. v. (1981). Depressive Symptomatik imstationären Behandlungsverlauf von 280 schizophrenen Patienten. Pharmakopsychiatrie, 14 172-179.Google Scholar
  23. Muller-Oerlinghausen, B., Ahrens, B., Grof, E., Grof, P., Lenz, G., Schou, M., Simhandl, C., Thau, K., Volk, J., Wolf, R. & et al. (1992a). The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta psychiatrica Scandinavica, 86(3), 218-22.Google Scholar
  24. Muller-Oerlinghausen, B., Muser-Causemann, B. & Volk, J. (1992b). Suicides and parasuicides in a hig-hrisk patient group on and off lithium long-term medication. Journal of Affective Disorders, 25(4), 261-9.Google Scholar
  25. Myers, D. & Neal, C. (1978). Suicide in psychiatric patients. British Journal of Psychiatry, 133 38-44.Google Scholar
  26. Nilsson, A. (1995). Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry, 28(1), 8-13.Google Scholar
  27. Norton, B. & Whalley, L. (1984). Mortality of a lithium treated population. British Journal of Psychiatry, 145 277-282.Google Scholar
  28. Pokorny, A. (1983). Prediction of suicide in psychiatric patients. Archives of General Psychiatry, 40 249-257.Google Scholar
  29. Price, L. H., Charney, D. S., Delgado, P. M. & Heninger, G. R. (1990). Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology, 100 3-12.Google Scholar
  30. Rouillon, F., Philipps, R. & Serrurier, D. (1989). Recurrence of unipolar depression efficacy of maprotiline. Encéphale, 15 527-534.Google Scholar
  31. Roy, A. (1982). Risk factors for suicide in psychiatric patients. Archives of General Psychiatry, 39(9), 1089-95.Google Scholar
  32. Roy, A. (1985). Suicide. A multidetermined act. Psychiatric Clinic of North America, 8(2), 243-50.Google Scholar
  33. Taiminen, J. & Kujari, H. (1994). Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients. Acta psychiatrica Scandinavica, 90 247-251.Google Scholar
  34. Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., Walther, A. & Greil, W. (1996). Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry, 29 103-107.Google Scholar
  35. Vestergaard, P. & Aagaard, J. (1991). Five-year mortality in lithium-treated manic-depressive patients. Journal of Affective Disorders, 21 33-38.Google Scholar
  36. Wickham, E. A. & Reed, J. V. (1987). Lithium for the control of aggressive and self-mutilating behaviour. International Clinical Psychopharmacology, 2 181-190.Google Scholar
  37. Wolfersdorf, M. (1989). Suizid bei stationären psychiatrischen Patienten. Regensburg: Roderer.Google Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Martin Krupinski
    • 1
  • Alfred Fischer
    • 1
  • Renate Grohmann
    • 1
  • Rolf R. Engel
    • 1
  • Matthias Hollweg
    • 1
  • Hans-Jürgen Möller
    • 1
  1. 1.Psychiatric HospitalUniversity of MunichMunichGermany

Personalised recommendations